{"name":"Foghorn Therapeutics Inc.","slug":"foghorn-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":30909000,"revenueGrowth":36.8,"grossMargin":0,"rdSpend":85466000,"netIncome":-74283000,"cash":80876000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE8wUF9VUjAtQnFvVklhMTl2bVdHd1czaENoZWdHOG16WVJ0UzN6YWpQbG43Zk5qSmtuRHZoODNYRlMxWmFTUkxNQVFGZFVJMTdFM2VlbC12X0FzQ1lqN0tWNVlhZGR0eVJfYmJQVWtR?oc=5","date":"2026-04-08","type":"pipeline","source":"Stock Titan","summary":"If You Invested $1,000 in Foghorn Therapeutics Inc. (FHTX) - Stock Titan","headline":"If You Invested $1,000 in Foghorn Therapeutics Inc. (FHTX)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxNUjBLQWcwcjFwUXlUb2s2dDRRcWxwX2V2MGxzWVh0c3VIdEJQdEJ2a3JnUFVBTng2N25mV3luVmtobTBPM3k3cF9ldS1sMVIyXzEwc2NZLTRWT0N5bmZnbG5FQW1jWFVSckR4SGRBOG5jczdfamZnWEl0LXMyTWtCM3p5NWNVX3p6Sy1jdlV4WTd6Vmh6cEozOHg1d05TWVVtVWtrZFEwUS1ybEFOam1tWnBveUVYTDNTemtxNkg0Mk1RRy1CX2NHLUhEYUtEQXJGMXZlQzhaQ0VqanlSdVhzNklxNDdUNVJRMHc?oc=5","date":"2026-03-11","type":"pipeline","source":"GlobeNewswire","summary":"Foghorn Therapeutics Provides Financial Update for 2025 and 2026 Strategic Outlook - GlobeNewswire","headline":"Foghorn Therapeutics Provides Financial Update for 2025 and 2026 Strategic Outlook","sentiment":"neutral"},{"date":"2026-03-11","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-03-11","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxORHVsTUJncm5UX1llaGxyM2ROaFNadjJweGk3SzFRdHUtZVhRZkJlSmZadnlNQWlaNm9MRDFuWmlXZjZzU1NWUEtoZ0NjTHYyZUNELVVTdWQzZG43cmZBTzBBUm9IalVfUDNIYmp3ZUJxVnd5NWJmNEZTSXE0blQtdU9rc0JJMGt6Y0RSaGp6LVN4YzVFTXF3cHZhaTRLRUgwVU9IU1VUUnl6c1VlUEd2NUNvMmtlWVR2YVhubi1LYkNxaENnQ21NTGVtRnVXRVBrRTdNemJn?oc=5","date":"2026-02-24","type":"pipeline","source":"The Globe and Mail","summary":"Foghorn Therapeutics Names Veteran Executive as New CFO - The Globe and Mail","headline":"Foghorn Therapeutics Names Veteran Executive as New CFO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxOWWc3MFZBNFZLaUdBUjFlLWpzMGFrVWN6Qm5DMW40SG1mV3ZxQy0yOUNZN1E0VlhsVllNU2JtNHNOZmFxdU1rMzBhSFlVREY5MzVTVlRZWGdyRVV1TU8temI5V2Y2V1JVM0dTVkVsNExWZUlEYlZTNGhEbXg5YmtBdEd1cUlBZXk5dmdlX1ItT0hUdm1BWk56ZDRERHBuQndINC1DZi1HSi1adEE?oc=5","date":"2026-02-23","type":"pipeline","source":"Quiver Quantitative","summary":"Foghorn Therapeutics Inc. Appoints Ryan Maynard as Chief Financial Officer - Quiver Quantitative","headline":"Foghorn Therapeutics Inc. Appoints Ryan Maynard as Chief Financial Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwJBVV95cUxOVVFmdmZIb2RRNjljc1phU0cwX01mT1lUUW5rU01KaHhBcy1MYlU3d3NkTXR5em9ta2R4cXdYUGNfM094WDlFSVY0T3hXUmtvSGRFdkY4VDJpcjV4aGZWTjdiOGRoZ1p4aFl0ZDF1YUtZSnlST2YzLTRTdk5YYUZQQkh4dk5yRVVkY2hubWhXQXY1MlkyQWF1V3NydDZMYnkyS2JoV1lNdTBwZ1VoWlZUejhVaTZVaWVSaHlTc1M3MU1WSGZPX3RBSTZmMmowaFhOaFFfUGlfUG9YMmp6Njd3Tmp4N0s2SUdqQnpCeTNIdzlLaHdXeFkxOEhMbm0xcENvc1VubjRBblJ1OTJuVFJXX3p5WQ?oc=5","date":"2026-02-23","type":"pipeline","source":"GlobeNewswire","summary":"Foghorn Therapeutics Strengthens Financial Leadership with Appointment of Ryan Maynard as Chief Financial Officer - GlobeNewswire","headline":"Foghorn Therapeutics Strengthens Financial Leadership with Appointment of Ryan Maynard as Chief Financial Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxQVFZuMXBfc0hqNE5yTDZCWERBWmxzWko4MGphUGxYSlJadFBfc3lRRWNsT1o2LVJCb1BxVUNDc3BKa1F5NFlCWHpQMFdDR0R2OXc3UE1aNUdTTDZzYldGbXQyZzVpcEdxSVdTc2NuTUd1UjFaaGc3TFo5Z0sxXzAzWEc0alVYV1hnTlJITFJuMUl6eU1BTEFzd3dybXgtY3Rtd0JTbUxoYTg3bEZtWThERkFRRQ?oc=5","date":"2026-02-23","type":"deal","source":"Stock Titan","summary":"Biotech CFO who raised $1B in deals joins Foghorn Therapeutics - Stock Titan","headline":"Biotech CFO who raised $1B in deals joins Foghorn Therapeutics","sentiment":"neutral"},{"date":"2026-02-23","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAJBVV95cUxNNGVpUFhJZW9tODl4ZFRiMGM5NDljUW9LRHppUVM2bXBVbFhUMEVWX1RCanQ3dWt5WV9URl9zLVVaVVpJa0lIbUNNYTNnRGduRE5iTGoyeUlNSm9zQ2ROSkZDZmQ4QUF3R0cyWTIzcTFBX1BTRXRYLU5kSVBFdnJMNi1CX1dLWm5tdEdoLU5UUVplOFdhUEVuZ1pvX3JnZFRWYVgwY0RmV1JSdWhMZVhSdTBJX3VTZ25EYzhBUkl3NkpyRTdxNXZybXhoZ1NreTZ6RWgxb3FtSVVKSXJLVTRvVEZkME1zS2VKdUFGWVdlZENfUnd3d3owdjBnMkdfdC1y?oc=5","date":"2026-01-27","type":"pipeline","source":"The Globe and Mail","summary":"Hard-to-Treat Cancers: How 2026’s Top Clinical Platforms Are Beating Industry Benchmarks - The Globe and Mail","headline":"Hard-to-Treat Cancers: How 2026’s Top Clinical Platforms Are Beating Industry Benchmarks","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxOQWsxaTRKZHdTalhSWlJUYUsyLVpibzZNNzE2SjludWlxay1xQVRIT2lGOVpXUGxDOWZhdVl2UGZJbGhuZUxodk5WWlFzV2h5SXc4SXFWTkxXeDdWUmUxczMwU2I5QnlrOXpwT1BLY0NwNnhyZ3o5M0luVzZLTy12bkU0S0VMS2tocHBTc0I2SjVjbEhvUnYwZnVRRTktMXRKSjgyVXlSbE5qTlRwRmtmWGdPMmdpeUZ2TmNCeERPaXl1SXNieFRGZkNvTHA2Wl9yUmc?oc=5","date":"2026-01-14","type":"patent","source":"PR Newswire","summary":"Precision Killers: Why Big Pharma is Betting Billions to Beat a $170B Patent Cliff - PR Newswire","headline":"Precision Killers: Why Big Pharma is Betting Billions to Beat a $170B Patent Cliff","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxOUW5NRUg4R1hteWhFeDNVaFRjM2xYYkJ0ZHp6LXFnTTBFaGJYdUUzTklXQ2lnUlIyVzBhbUdvd0gxWGFqV3B4TWVmVHc5eWlpN2RHcjE2T0cwVDNIX0RJdGM5RWtwMTAzclotajZTV1BhTkRGNjIxeHF5RTNwRWExakUyLTlQbjItaGxDVGpnZFNhbkY0V1hkbVVlcDdmQ2tRYldvWWQ5LXJQZzhianp1UnFmQUR5SnR0V2dRQ0EzSEpVZzVXV0NETGVINnZ0aVljOVJCeXF0c1J6RVdab2R2WGpKTmt4T1BDZDUtc2IzeDFKZEdjRzRqbFZCN3U?oc=5","date":"2026-01-13","type":"pipeline","source":"GlobeNewswire","summary":"Foghorn Therapeutics Announces Closing of $50 Million Registered Direct Financing at a 30% Premium - GlobeNewswire","headline":"Foghorn Therapeutics Announces Closing of $50 Million Registered Direct Financing at a 30% Premium","sentiment":"neutral"},{"date":"2026-01-12","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxPU2lwQmdCLUJlbGVVblEtdFdQWWpWSmtUeGFrbUlBRmNtMWVrXzVvSTVJMXhvRjhKRU1pRk94SUZsa1U5VmpnTGM1aUl5NGhzYnpCcHVMRU9VUlpQakpjT21qajRSQWpKbVh3UW1JV0NWVVRka1g0aTc1MllGYWlkTEd6VDBLX1ROVllqdWVQdzdDRGtzUzQ1b3Q4QUdBcXVnUlVaWVRkblZnTy0tNDNwX0YzRUMwZXlwZC1zVU9EV0RiZw?oc=5","date":"2025-12-11","type":"pipeline","source":"PR Newswire","summary":"Platform Technologies Drive $211B Surge in Precision Cancer Treatment - PR Newswire","headline":"Platform Technologies Drive $211B Surge in Precision Cancer Treatment","sentiment":"neutral"},{"date":"2025-12-04","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":30909000,"revenuePeriod":"2025-12-31","revenueHistory":[{"value":30909000,"period":"2025-12-31"},{"value":22602000,"period":"2024-12-31"},{"value":34155000,"period":"2023-12-31"},{"value":19228000,"period":"2022-12-31"},{"value":1319000,"period":"2021-12-31"},{"value":430000,"period":"2020-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":85466000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-74283000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":80876000,"cashHistory":[],"totalAssets":198103000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}